Experimentation with tobacco during adolescence as a factor influencing treatment of smoking in adulthood
A retrospective cohort
Keywords:
Adolescent, Tobacco, Nicotine, Treatment outcomeAbstract
BACKGROUND: There are still few studies on predictors of smoking cessation in Brazilian samples. Experi-mentation with tobacco during adolescence (ETA) may be one of the important predictors. OBJECTIVE: This study aimed, within the context of a treatment-seeking group of subjects, to test the hypothesis that ETA negatively affects the outcome of smoking cessation during adulthood. DESIGN AND SETTING: Retrospective (historic) cohort study conducted at a psychosocial care center in São Paulo, Brazil, between 2007 and 2010. METHODS: Data on sociodemographics, smoking and medical profiles were obtained through self-report questionnaires that were completed at the baseline and at any follow-up appointment. Logistic regression models were constructed to describe factors associated with the outcome of smoking cessation, mea-sured according to the self-reported four-week success rate among 367 outpatient smokers. RESULTS: ETA was found to be associated with not quitting smoking through the treatment (odds ratio = 0.57; 95% confidence interval = 0.33-0.96; P < 0.05), even after adjustment for dependence level, sociode-mographics, nicotine patch use and number of years of smoking. CONCLUSIONS: Early exposure to nicotine may lead to higher risk of continuing smoking after treat-ment, in adulthood.
Downloads
References
Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. Jama. 2014;311(2):183-92. PMID: 24399557; doi: 10.1001/jama.2013.284692.
Monteiro CA, Cavalcante TM, Moura EC, Claro RM, Szwarcwald CL. Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003). Bull World Health Organ. 2007;85(7):527-34. PMID: 17768501; doi: 10.2471/BLT.06.039073.
Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224-60. PMID: 23245609; doi: 10.1016/S0140-6736(12)61766-8.
GBD 2010 change in leading causes and risks between 1990 and 2010 [Internet]. Institute for Health Metrics and Evaluation. 2013.
Giovino GA, Mirza SA, Samet JM, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet. 2012;380(9842):668-79. PMID: 22901888; doi: 10.1016/S0140-6736(12)61085-X.
Laniado-Laborin R. Smoking cessation intervention: an evidence-based approach. Postgrad Med. 2010;122(2):74-82. PMID: 20203458; doi: 10.3810/pgm.2010.03.2124.
Zhu S, Melcer T, Sun J, Rosbrook B, Pierce JP. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med. 2000;18(4):305-11. PMID: 10788733; doi: 10.1016/S0749-3797(00)00124-0.
Vangeli E, Stapleton J, Smit ES, Borland R, West R. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction. 2011;106(12):2110-21. PMID: 21752135; doi: 10.1111/j.1360-0443.2011.03565.x.
West R, McEwen A, Bolling K, Owen L. Smoking cessation and smoking patterns in the general population: a 1-year follow-up. Addiction. 2001;96(6):891-902. PMID: 11399220; doi: 10.1080/09652140020051013.
França SA, Neves AL, Souza TA, et al. Fatores associados à cessação do tabagismo [Factors associated with smoking cessation]. Rev Saúde Pública. 2015;49:10. PMID: 25741649; doi: 10.1590/S0034-8910.2015049004946.
Prado GF, Lombardi EM, Bussacos MA, et al. A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success. Clinics (Sao Paulo). 2011;66(1):65-71. PMID: 21437438; doi: 10.1590/S1807-59322011000100012.
Abdolahinia A, Sadr M, Hessami Z. Correlation between the age of smoking initiation and maintaining continuous abstinence for 5 years after quitting. Acta Med Iran. 2012;50(11):755-9. PMID: 23292627.
Lydon DM, Wilson SJ, Child A, Geier CF. Adolescent brain maturation and smoking: what we know and where we’re headed. Neurosci Biobehav Rev. 2014;45:323-42. PMID: 25025658; doi: 10.1016/j. neubiorev.2014.07.003.
Kendler KS, Myers J, Damaj MI, Chen X. Early smoking onset and risk for subsequent nicotine dependence: a monozygotic co-twin control study. Am J Psychiatry. 2013;170(4):408-13. PMID: 23318372; doi: 10.1176/ appi.ajp.2012.12030321.
Loreto AR, Carvalho CFC, Frallonardo FP, et al. Smoking Cessation Treatment for Patients With Mental Disorders Using CBT and Combined Pharmacotherapy. J Dual Diagn. 2017;13(4):238-46. PMID: 28489501; doi: 10.1080/15504263.2017.1328149.
Castaldelli-Maia JM, Loreto AR, Guimarães-Pereira BBS, et al. Smoking cessation treatment outcomes among people with and without mental and substance use disorders: An observational real-world study. Eur Psychiatry. 2018;52:22-28. PMID: 29609056; doi: 10.1016/j. eurpsy.2018.02.005.
Castaldelli-Maia JM, Carvalho CF, Armentano F, et al. Outcome predictors of smoking cessation treatment provided by an addiction care unit between 2007 and 2010. Brazilian J Psychiatry. 2013;35(4):338-46. PMID: 24402207; doi: 10.1590/1516-4446-2012-0907.
Castaldelli-Maia JM, Loreto AR, Carvalho CF, Frallonardo FP, de Andrade AG. Retention predictors of a smoking treatment provided by a public psychosocial unit in Brazil. Int Rev Psychiatry. 2014;26(4):515-23. PMID: 25137119; doi: 10.3109/09540261.2014.928272.
Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507-20. PMID: 27116918; doi: 10.1016/S0140-6736(16)30272-0.
Freedman KS, Nelson NM, Feldman LL. Smoking initiation among young adults in the United States and Canada, 1998-2010: a systematic review. Prev Chronic Dis. 2012;9:E05. PMID: 22172172; doi: 10.5888/ pcd9.110037.
West R. Assessing smoking cessation performance in NHS Stop Smoking Services: The Russell Standard (Clinical). Internet [2005]. Available from: http://wwwncsctcouk/usr/pub/assessing-smoking-cessation-performance-in-nhs-stop-smoking-services-the-russell-standard-clinicalpdf. Accessed in 2018 (May 25).
Park SM, Son KY, Lee YJ, et al. A preliminary investigation of early smoking initiation and nicotine dependence in Korean adults. Drug Alcohol Depend. 2004;74(2):197-203. PMID: 15099663; doi: 10.1016/j. drugalcdep.2004.01.001.
Sussman S, Dent CW, Severson H, Burton D, Flay BR. Self-initiated quitting among adolescent smokers. Prev Med. 1998;27(5 Pt 3):A19-28. PMID: 9808814; doi: 10.1006/pmed.1998.0379.
Veroude K, Jolles J, Croiset G, Krabbendam L. Changes in neural mechanisms of cognitive control during the transition from late adolescence to young adulthood. Dev Cogn Neurosci. 2013;5:63-70. PMID: 23376475; doi: 10.1016/j.dcn.2012.12.002.
Tamnes CK, Ostby Y, Walhovd KB, et al. Neuroanatomical correlates of executive functions in children and adolescents: a magnetic resonance imaging (MRI) study of cortical thickness. Neuropsychologia. 2010;48(9):2496-508. PMID: 20434470; doi: 10.1016/j. neuropsychologia.2010.04.024.
Paus T, Zijdenbos A, Worsley K, et al. Structural maturation of neural pathways in children and adolescents: in vivo study. Science. 1999;283(5409):1908-11. PMID: 10082463; doi: 10.1126/ science.283.5409.1908.
Dwyer JB, McQuown SC, Leslie FM. The dynamic effects of nicotine on the developing brain. Pharmacol Ther. 2009;122(2):125-39. PMID: 19268688; doi: 10.1016/j.pharmthera.2009.02.003.
Mashhoon Y, Betts J, Farmer SL, Lukas SE. Early onset cigarette smokers exhibit greater P300 reactivity to smoking-related stimuli and report greater craving. Brain Res. 2018;1687:173-84. PMID: 29524436; doi: 10.1016/j.brainres.2018.02.037.
Holm M, Schioler L, Andersson E, et al. Predictors of smoking cessation: A longitudinal study in a large cohort of smokers. Respir Med. 2017;132:164-9. PMID: 29229092; doi: 10.1016/j.rmed.2017.10.013.
Aveyard P, Bauld L. Incentives for promoting smoking cessation: What we still do not know. The Cochrane database of systematic reviews. 2011;Apr13(8):ED000027. PMID: 21833985; doi: 10.1002/14651858. ED000027.
Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. Am J Public Health. 2013;103(5):923-30. PMID: 23488521; doi: 10.2105/AJPH.2012.301070.
Castaldelli-Maia JM, Martins SS, Walker N. The effectiveness of Cytisine versus Nicotine Replacement Treatment for smoking cessation in the Russian Federation. Int J Drug Policy. 2018;58:121-5. PMID: 29929154; doi: 10.1016/j.drugpo.2018.05.012.
Castaldelli-Maia JM, Martins SS, Storr CL, et al. Investigating the dimensional diagnosis of ICD-11 nicotine dependence. Psychol Addict Behav. 2018;32(4):415-25. PMID: 29927280; doi: 10.1037/adb0000369.
Castaldelli-Maia JM, Andrade LH, Storr CL, et al. The latent trait of ICD-11 nicotine dependence criteria: Dimensional and categorical phenotypes. Psychiatry Res. 2018;266:275-83. PMID: 29605101; doi: 10.1016/j.psychres.2018.03.018.
